FIELD: medicine, pharmacology, pharmacy, antibiotics.
SUBSTANCE: invention relates to a prodrug representing a cyclic undecapeptide wherein its peptide chain comprises at least one amino acid residue of the general formula (I) given in the invention description wherein carbon atom Ca form one bond among bonds in the undecapeptide ring; each substitute among Y substitutes represents hydrogen atom, or they form a bond in common; substitutes R1 and R3 represent independently of one another hydrogen atom, the group aralkyl, alkaryl, heteroalkyl, heterocycle, alkylheterocycle, heterocycloalkyl or direct or branched alkyl comprising 1-6 carbon atoms wherein indicated groups are substituted optionally with at least one group chosen from: -COOH, -CONHR8, -NHC=NH(NH2), - NHC=NR8(NH2), -NH2, -NHR8, -NR8 2, -N+R8 3, -OH, -OPO(OR)2, -OPO(OH)(OR8), -OPO(OH)2, -OSO(OR8)2, -0SO(OH)(OR8), -OSO(OH)2 and different saline forms of these groups wherein each group among substitutes R8 independently of one another represents a direct or branched alkyl comprising 1-6 carbon atoms; substitutes R2 and R4 represent independently of one another hydrogen atom, alkaryl group or direct or branched alkyl comprising 1-6 carbon atoms; substitutes R and R6 represent independently of one another hydrogen atom, aralkyl group or direct or branched alkyl comprising 1-6 carbon atoms; substitute R7 represents the group aralkyl, alkaryl, heteroalkyl, heterocycle, alkylheterocycle, heterocycloalkyl, or direct or branched alkyl. Also, invention relates to using the indicated prodrug for preparing a medicinal agent used in treatment of pathological states of mucous membranes. Invention provides enhancing availability of the drug in its using.
EFFECT: valuable medicinal properties of drug.
17 cl, 5 tbl, 3 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
CYCLOSPORINE | 1991 |
|
RU2085589C1 |
NONIMMUNOSUPPRESSIVE CYCLOSPORINE FOR TREATING CONGENITAL ULLRICH MYOPATHY | 2008 |
|
RU2462262C2 |
USE OF MODIFIED CYCLOSPORINES | 2007 |
|
RU2463071C2 |
APPLICATION OF MODIFIED CYCLOSPORINS FOR TREATING HCV INDUCED DISEASES | 2004 |
|
RU2389501C2 |
NOVEL CYCLOSPORIN DERIVATIVES FOR TREATMENT AND PREVENTION OF VIRAL INFECTIONS | 2011 |
|
RU2601742C2 |
DERIVATIVES OF CYCLOSPORIN, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON SAID | 1993 |
|
RU2131883C1 |
AGENT FOR HAIR GROWTH CONTAINING 3-SUBSTITUTED CYCLOSPORINE DERIVATIVE | 2002 |
|
RU2291682C2 |
CYCLOSPORINE DERIVATIVES FOR TREATING OPHTHALMIC AND SKIN DISEASES AND CONDITIONS | 2009 |
|
RU2521358C2 |
PEPTIDE VECTORS | 2004 |
|
RU2361876C2 |
METASTIN DERIVATIVES AND USE THEREOF | 2007 |
|
RU2454425C2 |
Authors
Dates
2006-12-27—Published
2002-04-22—Filed